Bimekizumab versus Secukinumab in Plaque Psoriasis

Reich, K; Warren, RB; Lebwohl, M; Gooderham, M; Strober, B; Langley, RG; Paul, C; De Cuyper, D; Vanvoorden, V; Madden, C; Cioffi, C; Peterson, L; Blauvelt, A

Reich, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Martinistr 52, D-20246 Hamburg, Germany.

NEW ENGLAND JOURNAL OF MEDICINE, 2021; 385 (2): 142

Abstract

BACKGROUND Bimekizumab is a monoclonal IgG1 antibody that selectively inhibits both interleukin-17A and interleukin-17F. The efficacy and safety of bi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索